PharmaRoth Labs, Inc. Stock Other OTC
Equities
ROTH
US71715Y1029
Pharmaceuticals
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 5.74M |
---|---|---|---|---|---|
Net income 2009 | - | Net income 2010 | - | EV / Sales 2009 | - |
Net Debt 2009 | 12.5K | Net Debt 2010 | 286K | EV / Sales 2010 | - |
P/E ratio 2009 |
-777
x | P/E ratio 2010 |
-7.8
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 30.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 13-01-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 |
1st Jan change | Capi. | |
---|---|---|
+26.47% | 664B | |
+30.71% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+14.51% | 234B | |
+5.09% | 199B | |
-10.06% | 196B | |
-4.04% | 148B |